Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant Enterococcus

Vancomycin-resistant enterococci (VRE) are the second leading cause of hospital-acquired infections (HAIs) attributed to a drug-resistant bacterium in the United States, and resistance to the front...